Expertiseback to overview
The innovation ecosystem comes with years of expertise. It all starts at the bench in academic research institutes – Flanders is home to excellent life sciences research groups, led by experienced internationally recognize principal investigators.
Intensive and efficient collaborations with industry – often facilitated by the technology transfer departments of the different universities and research centers – resulted in several globally recognized and successful ventures.
The expertise available at the different biopharmaceutical companies has been a strong driver, and allowed for spin-outs, collaborations and M&A resulting in better solutions for the patients. Flanders’ pipeline for health solution companies is quite impressive:
130 products in the pipeline (SME+big pharma)
46 products in clinical trials
5 products in status of approval
13 products on the market
Belgium as an European leader in clinical trials
Flanders and Wallonia join forces to positioning Belgium as the European leader for phase I and II clinical trials. Belgium has 64 trials in phase I and 128 in phase II. The fast approval of only 2 weeks, is very attractive to organizers of clinical trials. And most importantly, the flawless execution of complex trials is one of the biggest assets.
Number of trials starting per million inhabitants: